Advertisement

Topics

With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug

12:32 EDT 1 Aug 2017 | Xconomy

The FDA approved a new blood cancer drug today. Called enasidenib (Idhifa), it’s the latest therapy sold by Celgene, the big cancer drugmaker from Summit, NJ. But the news is significant for other reasons. First, the drug is the first product to come from the labs of Agios Pharmaceuticals (NASDAQ: AGIO). The Cambridge, MA, firm […]

Original Article: With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug

NEXT ARTICLE

More From BioPortfolio on "With FDA Nod, Agios, Celgene Get Speedy OK For Blood Cancer Drug"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...